To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene BRMS1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
241 supporting clones for gene BRMS1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK310991 uterus .a 1 to 1352 1 to 1286 G140E A141R K142I H144R S147E ... tiling clone, Suspected internal deletion 1286/1286
(100 %)
1 diff
(100.0 %id)
BM689300 eye, optic nerve .a 1305 to 1782 9 to 486   tiling clone,   478/486
(98 %)
6 diff
(98.8 %id)
BM148492 leukopheresis .a 1472 to 1788 317 to 1   tiling clone,   317/317
(100 %)
2 diff
(99.4 %id)
BU727413 eye, optic nerve .a 1805 to 2150 364 to 19   tiling clone, AAA   346/346
(100 %)
4 diff
(98.9 %id)
DB251787 uterus .b 1 to 537 2 to 538   tiling clone, capped   537/537
(100 %)
1 diff
(99.9 %id)
DB268729 uterus .b 1 to 273 2 to 274   capped   273/273
(100 %)
1 diff
(99.7 %id)
DA374786 thalamus .b 2 to 556 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DA041022 bladder .b 7 to 570 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
CB130346 Liver .b 8 to 454 1 to 447       447/447
(100 %)
1 diff
(99.8 %id)
BP297208   .b 8 to 589 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BF037901 adenocarcinoma, ovary .b 14 to 81 1 to 68       68/68
(100 %)
0 diff
(100 %id)
DA612454   .b 15 to 582 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
BG684476 B-cells, primary B-cells from tonsils (cell line) .b 16 to 598 1 to 584       584/590
(98 %)
3 diff
(99.5 %id)
BF531086 anaplastic oligodendroglioma with 1p/19qloss, brain .b 18 to 101 1 to 84       84/84
(100 %)
0 diff
(100 %id)
CB136325 Liver .b 20 to 549 1 to 530       530/530
(100 %)
2 diff
(99.7 %id)
CB135830 Liver .b 21 to 438 1 to 418       418/418
(100 %)
1 diff
(99.8 %id)
CB131446 Liver .b 21 to 390 1 to 371       371/371
(100 %)
0 diff
(100 %id)
CB108700 Liver .b 22 to 569 1 to 548       548/548
(100 %)
3 diff
(99.5 %id)
DA909310   .b 22 to 510 2 to 490   capped   489/489
(100 %)
1 diff
(99.8 %id)
BP303895   .b 24 to 597 1 to 573       573/581
(98 %)
25 diff
(95.7 %id)
AL037035 brain .b 29 to 246 1 to 219       217/219
(99 %)
6 diff
(97.3 %id)
AL702705 human skeletal muscle .b 30 to 218 1 to 189       189/189
(100 %)
6 diff
(96.9 %id)
AL702715 human skeletal muscle .b 30 to 321 1 to 292       292/292
(100 %)
1 diff
(99.7 %id)
CN345833 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 32 to 498 10 to 476       467/476
(98 %)
7 diff
(98.6 %id)
CR620223 Placenta Cot 25-normalized .b 36 to 1852 1 to 1817 exact tiling clone,   1817/1817
(100 %)
0 diff
(100 %id)
BX398430 Placenta Cot 25-normalized .b 36 to 937 1 to 889   fully sequenced,   889/889
(100 %)
6 diff
(99.4 %id)
BI094150 cervix .b 36 to 101 1 to 66       66/66
(100 %)
0 diff
(100 %id)
CR996284 T-Lymphocytes .b 37 to 597 1 to 561       561/563
(99 %)
2 diff
(99.7 %id)
BG391544 embryonal carcinoma, cell line, testis .b 38 to 101 1 to 63       63/63
(100 %)
1 diff
(98.5 %id)
CN345831 embryonic stem cells, cell lines H1, H7, andH9 .b 40 to 241 1 to 204       204/204
(100 %)
1 diff
(99.6 %id)
BM014765 breast, mammary adenocarcinoma, cell line .b 40 to 101 1 to 62       62/62
(100 %)
0 diff
(100 %id)
BG166370 hypernephroma, cell line, Kidney .b 41 to 101 1 to 61       61/61
(100 %)
0 diff
(100 %id)
BM313251 Pancreas, Purified pancreatic islet .b 42 to 585 1 to 544       544/545
(99 %)
4 diff
(99.3 %id)
BG283362 adenocarcinoma, cell line, Prostate .b 46 to 101 12 to 67       56/67
(83 %)
6 diff
(91.1 %id)
CN345830 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 49 to 321 1 to 273       273/273
(100 %)
0 diff
(100 %id)
BM716328 eye, RPE and Choroid .b 51 to 475 1 to 425       425/430
(98 %)
2 diff
(99.6 %id)
BM462462 leiomyosarcoma, uterus .b 52 to 597 1 to 551   AAA   551/963
(57 %)
11 diff
(98.9 %id)
BE265684 lung, small cell carcinoma .b 62 to 579 1 to 518       518/520
(99 %)
1 diff
(99.9 %id)
DT217143 brain .b 66 to 507 1 to 443       443/443
(100 %)
10 diff
(97.8 %id)
BM790905 stomach .b 68 to 559 1 to 490       490/490
(100 %)
1 diff
(99.8 %id)
BM795142 stomach .b 68 to 413 1 to 344       344/344
(100 %)
2 diff
(99.5 %id)
BM855977 stomach .b 68 to 318 1 to 251       251/251
(100 %)
2 diff
(99.3 %id)
BM846377 myeloma .b 69 to 380 9 to 318       310/318
(97 %)
8 diff
(97.5 %id)
DA934901 Spleen .b 70 to 527 2 to 459   capped   458/458
(100 %)
0 diff
(100 %id)
AW239454 lung, cell line .b 76 to 528 1 to 453       453/453
(100 %)
2 diff
(99.6 %id)
BG821815 adenocarcinoma cell line, colon .b 90 to 598 1 to 517       517/872
(59 %)
15 diff
(98.3 %id)
BI060037 uterus_tumor .b 117 to 542 1 to 426       426/426
(100 %)
4 diff
(99.1 %id)
BX093630 pooled .b 120 to 486 1 to 367       367/369
(99 %)
6 diff
(98.4 %id)
BF088385 head_neck .b 181 to 511 332 to 2       331/332
(99 %)
2 diff
(99.4 %id)
BF081836 amnion_normal .b 216 to 422 32 to 238       207/240
(86 %)
8 diff
(96.7 %id)
BI008551 kidney_tumor .b 268 to 392 129 to 6       124/129
(96 %)
0 diff
(100 %id)
BF088472 head_neck .b 343 to 530 1 to 188       188/191
(98 %)
4 diff
(98.0 %id)
BE281061 choriocarcinoma, placenta .b 582 to 1243 28 to 697       670/774
(86 %)
34 diff
(95.7 %id)
BE900241 choriocarcinoma, placenta .b 616 to 1366 1 to 743       743/744
(99 %)
18 diff
(97.6 %id)
BX398429 Placenta Cot 25-normalized .b 907 to 1852 941 to 1   fully sequenced,   941/941
(100 %)
18 diff
(98.1 %id)
BU734281 eye, RPE and Choroid .b 1295 to 1888 611 to 19   tiling clone, AAA   593/593
(100 %)
2 diff
(99.7 %id)
BX359169 Placenta Cot 25-normalized .b 1324 to 1853 539 to 1       539/989
(54 %)
22 diff
(97.8 %id)
DB351141 uterus .b 1350 to 1881 533 to 1       533/533
(100 %)
3 diff
(99.5 %id)
AA400619   .b 1383 to 1875 13 to 504       492/504
(97 %)
6 diff
(98.9 %id)
NM_001024957.1   .c 1 to 1359 2 to 1360 exact RefSeq,   1360/1360
(100 %)
5 diff
(99.7 %id)
BQ421277 large cell carcinoma, lung .c 4 to 785 1 to 791   tiling clone,   789/929
(84 %)
11 diff
(98.9 %id)
BP330700 rectum .c 4 to 601 1 to 597       597/597
(100 %)
1 diff
(99.9 %id)
BG030527 breast, mammary adenocarcinoma, cell line .c 6 to 775 1 to 775       775/903
(85 %)
33 diff
(96.4 %id)
BP381426 adipose tissue .c 8 to 624 1 to 617       617/617
(100 %)
1 diff
(99.9 %id)
BP351160   .c 8 to 591 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BP222561   .c 10 to 594 1 to 584       584/584
(100 %)
3 diff
(99.5 %id)
BG535751 lung .c 10 to 691 1 to 701       697/802
(86 %)
31 diff
(96.2 %id)
BP303788   .c 10 to 592 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
DA072335 cerebellum .c 14 to 601 2 to 589   capped   588/589
(99 %)
3 diff
(99.5 %id)
AL037034 brain .c 16 to 760 1 to 745       745/746
(99 %)
18 diff
(97.6 %id)
CR995280 T-Lymphocytes .c 17 to 797 1 to 781   tiling clone,   781/784
(99 %)
2 diff
(99.8 %id)
BI836574 pooled pancreas and spleen .c 19 to 870 1 to 856       856/856
(100 %)
11 diff
(98.8 %id)
TI_57167584   .c 19 to 870 71 to 926       856/926
(92 %)
17 diff
(98.2 %id)
BI771317 pooled lung and spleen .c 23 to 837 1 to 887       649/909
(71 %)
62 diff
(93.2 %id)
CX165661 human embryonic stem cells differentiated toan early endodermal cell type .c 23 to 798 1 to 776       776/776
(100 %)
2 diff
(99.8 %id)
CR977369 T-Lymphocytes .c 23 to 846 1 to 824       824/831
(99 %)
2 diff
(99.8 %id)
CR975318 T-Lymphocytes .c 23 to 771 1 to 753       753/756
(99 %)
6 diff
(99.3 %id)
BQ939996 leiomyosarcoma, uterus .c 24 to 681 1 to 658       658/927
(70 %)
6 diff
(99.4 %id)
CB123640 Liver .c 24 to 638 1 to 615       615/615
(100 %)
1 diff
(99.9 %id)
BE732121 choriocarcinoma, placenta .c 25 to 711 1 to 687       687/687
(100 %)
3 diff
(99.6 %id)
BQ069890 brain, neuroblastoma, cell line .c 25 to 858 1 to 843       843/1045
(80 %)
21 diff
(98.0 %id)
BU838210 melanotic melanoma, cell line, skin .c 25 to 775 1 to 754       754/868
(86 %)
14 diff
(98.4 %id)
BI823834 pooled brain, lung, testis .c 26 to 742 1 to 716       716/717
(99 %)
9 diff
(98.8 %id)
CX167416 human embryonic stem cells differentiated toan early endodermal cell type .c 26 to 819 1 to 794       794/794
(100 %)
2 diff
(99.8 %id)
TI_57201087   .c 26 to 742 32 to 747       716/748
(95 %)
12 diff
(98.4 %id)
TI_59392822   .c 26 to 681 58 to 716       659/778
(84 %)
8 diff
(99.0 %id)
BY995629   .c 26 to 655 9 to 638       630/638
(98 %)
7 diff
(99.0 %id)
BM794113 Ascites, stomach .c 26 to 634 1 to 609       609/609
(100 %)
4 diff
(99.4 %id)
DN997036 breast cancer, Mammary gland (cancer tissue) .c 26 to 629 1 to 604       604/604
(100 %)
5 diff
(99.2 %id)
BE798930 lung, small cell carcinoma .c 27 to 876 20 to 876       820/987
(83 %)
30 diff
(97.0 %id)
BQ674777 epidermoid carcinoma, cell line, salivary gland .c 28 to 880 1 to 857       857/867
(98 %)
9 diff
(99.0 %id)
BQ673670 epidermoid carcinoma, cell line, salivary gland .c 28 to 775 1 to 750       750/906
(82 %)
26 diff
(97.2 %id)
DR156591 human embryonic stem cells differentiated toan early endodermal cell type .c 29 to 627 1 to 599       599/599
(100 %)
1 diff
(99.9 %id)
BE515266 endometrium, adenocarcinoma cell line, uterus .c 31 to 870 28 to 864       839/896
(93 %)
22 diff
(97.6 %id)
BI752888 brain .c 31 to 785 1 to 756       756/886
(85 %)
19 diff
(97.9 %id)
TI_154185597   .c 32 to 779 115 to 853       739/955
(77 %)
13 diff
(98.7 %id)
BE902514 choriocarcinoma, placenta .c 34 to 844 1 to 811       782/840
(93 %)
50 diff
(94.1 %id)
AW732306 Kidney, renal cell adenocarcinoma .c 37 to 526 1 to 490       490/490
(100 %)
0 diff
(100 %id)
CB215122 normal endometrium, late proliferativephase, cycle day 13, uterus .c 38 to 614 8 to 584       577/584
(98 %)
6 diff
(99.0 %id)
BQ059745 lymph, lymphoma, cell line .c 40 to 858 1 to 819       819/995
(82 %)
17 diff
(98.3 %id)
BI771307 pooled lung and spleen .c 41 to 847 1 to 833       831/845
(98 %)
41 diff
(95.2 %id)
TI_57179145   .c 41 to 847 33 to 865       831/877
(94 %)
46 diff
(94.8 %id)
BE265508 lung, small cell carcinoma .c 48 to 739 1 to 684       684/703
(97 %)
21 diff
(97.1 %id)
BE792276 lung, small cell carcinoma .c 51 to 721 1 to 672       672/674
(99 %)
4 diff
(99.5 %id)
DA924683 small intestine .c 58 to 616 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BE798064 lung, small cell carcinoma .c 62 to 845 20 to 796       777/1021
(76 %)
20 diff
(98.1 %id)
BE799248 lung, small cell carcinoma .c 62 to 837 29 to 796       771/1041
(74 %)
22 diff
(97.9 %id)
BE902998 choriocarcinoma, placenta .c 64 to 837 1 to 772       772/999
(77 %)
18 diff
(98.2 %id)
BG681822 skin, squamous cell carcinoma .c 65 to 870 1 to 806       806/806
(100 %)
7 diff
(99.2 %id)
BQ892789 melanotic melanoma, cell line, skin .c 65 to 666 1 to 606       606/951
(63 %)
7 diff
(99.3 %id)
BQ676364 melanotic melanoma, cell line, skin .c 65 to 775 1 to 712       711/981
(72 %)
11 diff
(98.9 %id)
BQ682191 melanotic melanoma, cell line, skin .c 65 to 682 1 to 617       617/920
(67 %)
15 diff
(98.4 %id)
BQ894605 melanotic melanoma, cell line, skin .c 65 to 682 1 to 618       618/1070
(57 %)
7 diff
(99.4 %id)
CA487347   .c 68 to 880 1 to 820       820/913
(89 %)
20 diff
(97.9 %id)
BU186282 large cell carcinoma, lung .c 69 to 814 1 to 753       753/900
(83 %)
18 diff
(98.0 %id)
CN345835 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 94 to 774 1 to 682       682/682
(100 %)
1 diff
(99.9 %id)
BG248952 hypernephroma, cell line, Kidney .c 101 to 627 1 to 535       535/718
(74 %)
13 diff
(98.2 %id)
BG179575 adenocarcinoma, cell line, Prostate .c 107 to 708 1 to 602       602/602
(100 %)
1 diff
(99.9 %id)
BQ216665 large cell carcinoma, lung .c 109 to 1003 1 to 913       913/913
(100 %)
39 diff
(95.8 %id)
TI_57179156   .c 114 to 858 143 to 944       670/945
(70 %)
75 diff
(92.1 %id)
CR457173   .c 147 to 880 1 to 734       734/741
(99 %)
2 diff
(99.8 %id)
EL733447 mixed .c 147 to 765 1 to 619       619/619
(100 %)
2 diff
(99.7 %id)
CN345834 embryonic stem cells, DMSO-treated H9 cellline .c 157 to 622 1 to 467       467/467
(100 %)
3 diff
(99.4 %id)
CB997510 placenta, pre-eclamptic placenta .c 220 to 750 27 to 557       531/568
(93 %)
8 diff
(98.6 %id)
AW248438 lung, small cell carcinoma .c 285 to 737 21 to 473       457/473
(96 %)
7 diff
(98.6 %id)
BM911025 astrocytoma grade IV, cell line, brain .c 287 to 858 1 to 575       575/1069
(53 %)
19 diff
(98.3 %id)
BE266344 lung, small cell carcinoma .c 290 to 725 1 to 437       437/437
(100 %)
4 diff
(99.1 %id)
AL050008 brain .c 294 to 1354 4 to 1064   available from DKFZ, AAA   1061/1061
(100 %)
7 diff
(99.4 %id)
TI_159724087   .c 421 to 1347 1019 to 109   AAA   911/1001
(91 %)
31 diff
(97.0 %id)
TI_1948241585   .c 583 to 880 904 to 607     Submitted on the opposite strand 298/1293
(23 %)
17 diff
(98.7 %id)
CB529276 Aveolar Macrophage, lung .c 585 to 1347 782 to 19   tiling clone, AAA   764/764
(100 %)
3 diff
(99.7 %id)
CA944756 Human Lung Epithelial cells, lung .c 701 to 1347 665 to 19   AAA   647/647
(100 %)
5 diff
(99.3 %id)
AW139758   .c 870 to 1353 501 to 18   AAA   484/484
(100 %)
6 diff
(98.8 %id)
AI684828 pooled .c 895 to 1346 452 to 1       452/452
(100 %)
1 diff
(99.8 %id)
AI476600 pooled .c 898 to 1337 449 to 10       440/449
(97 %)
0 diff
(100 %id)
AW663710 pooled .c 903 to 1346 444 to 1       444/444
(100 %)
1 diff
(99.8 %id)
AW250439 lung, small cell carcinoma .c 917 to 1347 441 to 11   tiling clone, AAA   431/431
(100 %)
0 diff
(100 %id)
EC559958 Prostate .c 921 to 1013 1 to 93       93/93
(100 %)
0 diff
(100 %id)
BG112368 Bone, osteosarcoma, cell line .c 926 to 1347 1 to 421   AAA   421/421
(100 %)
7 diff
(98.4 %id)
AW054923 adenocarcinoma, Pancreas .c 936 to 1347 426 to 15   AAA   412/412
(100 %)
13 diff
(96.9 %id)
AW006018 anaplastic oligodendroglioma, brain .c 936 to 1347 446 to 35   AAA   412/415
(99 %)
35 diff
(91.6 %id)
AA767299 germinal center B cell .c 959 to 1354 429 to 34   tiling clone, AAA   396/396
(100 %)
2 diff
(99.5 %id)
AJ346019 pectoral muscle (after mastectomy) .c 970 to 1344 12 to 386       375/386
(97 %)
6 diff
(98.5 %id)
AI582828 anaplastic oligodendroglioma, brain .c 1010 to 1347 353 to 16   AAA   338/338
(100 %)
2 diff
(99.5 %id)
BU731319 eye, RPE and Choroid .c 1020 to 1347 346 to 19   AAA   328/328
(100 %)
4 diff
(98.8 %id)
EC442515 Prostate .c 1027 to 1112 15 to 100       86/100
(86 %)
6 diff
(94.0 %id)
AI749064 colon .c 1048 to 1347 301 to 1       301/301
(100 %)
24 diff
(92.1 %id)
AW733096 Kidney, renal cell adenocarcinoma .c 1063 to 1354 308 to 17   AAA   292/292
(100 %)
7 diff
(97.7 %id)
BF475267 pooled germ cell tumors .c 1151 to 1347 217 to 21   AAA   197/197
(100 %)
1 diff
(99.5 %id)
BG758268 B-cells, primary B-cells from tonsils (cell line) .d 1 to 804 1 to 804 R226S P227A V230R C231L L244V ... tiling clone,   804/810
(99 %)
9 diff
(98.9 %id)
CA418655 Chondrosarcoma Grade II, Left Pelvis .d 517 to 1138 640 to 19   tiling clone, AAA   622/622
(100 %)
6 diff
(99.1 %id)
AK313773 testis .e 1 to 970 2 to 971 exact tiling clone,   971/971
(100 %)
1 diff
(99.9 %id)
DB050770 testis .e 1 to 556 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
NM_015399.3   .f 1 to 1437 1 to 1437 exact RefSeq, AAA   1437/1437
(100 %)
0 diff
(100 %id)
BU538881 adenocarcinoma, cell line, breast .f 16 to 901 1 to 894 L217A Q218S E219R I220E D221R ... tiling clone,   894/896
(99 %)
15 diff
(98.4 %id)
CR617683 Placenta Cot 25-normalized .f 23 to 1376 1 to 1354 exact     1354/1354
(100 %)
0 diff
(100 %id)
BX337569 Placenta Cot 25-normalized .f 23 to 713 1 to 687   fully sequenced,   687/687
(100 %)
6 diff
(99.2 %id)
CR617084 fetal brain .f 24 to 1403 1 to 1380 exact     1380/1380
(100 %)
0 diff
(100 %id)
AL539359 brain, fetal brain .f 24 to 806 1 to 780   fully sequenced,   780/780
(100 %)
7 diff
(99.2 %id)
CR599820 T cells (Jurkat cell line) Cot10-normalized .f 25 to 1407 1 to 1383 exact tiling clone,   1383/1383
(100 %)
0 diff
(100 %id)
CR618839 T cells (Jurkat cell line) Cot10-normalized .f 25 to 1401 1 to 1377 exact     1377/1377
(100 %)
0 diff
(100 %id)
BX402232.
matches multiple genes
placenta, Placenta Cot 25-normalized .f 25 to 806 1 to 782   fully sequenced, also hits gene EFNA1 782/782
(100 %)
10 diff
(98.8 %id)
AL558148 T cells from T cell leukemia .f 25 to 806 1 to 782   fully sequenced,   782/782
(100 %)
9 diff
(98.9 %id)
AL559206 T cells from T cell leukemia .f 25 to 713 1 to 685   fully sequenced,   685/685
(100 %)
13 diff
(98.2 %id)
AF159141 Kidney .f 27 to 1430 1 to 1411 exact tiling clone, AAA   1411/1411
(100 %)
10 diff
(99.3 %id)
TI_57219712   .f 32 to 909 58 to 943 K69A Q70V F71L S72G E73A ...     886/943
(93 %)
30 diff
(96.9 %id)
BI755219 brain .f 34 to 890 1 to 864 Q4H P5A P6S S7K K8Q ...     865/866
(99 %)
21 diff
(97.6 %id)
TI_57215822   .f 34 to 890 30 to 893 Q4H P5A P6S S7K K8Q ...     863/895
(96 %)
27 diff
(97.0 %id)
CA454165   .f 40 to 923 1 to 892 L167A E168G E169G D170G R171P ...     892/892
(100 %)
18 diff
(98.0 %id)
CR620200 adult brain .f 41 to 1405 1 to 1365 exact     1365/1365
(100 %)
0 diff
(100 %id)
BX463337 adult brain, brain .f 41 to 806 1 to 765   fully sequenced,   765/765
(100 %)
2 diff
(99.8 %id)
BC009834 Placenta, choriocarcinoma .f 45 to 1430 1 to 1386 exact available from MGC, AAA   1386/1386
(100 %)
3 diff
(99.8 %id)
CR988657 T-Lymphocytes .f 60 to 899 1 to 845 C126W L127S D128G V129C I130D ...     845/848
(99 %)
11 diff
(98.8 %id)
BQ681248 melanotic melanoma, cell line, skin .f 66 to 959 1 to 895 K231R A232L R233G A234Q A235L ...     895/950
(94 %)
15 diff
(98.5 %id)
BM557796 astrocytoma grade IV, cell line, brain .f 71 to 1044 1 to 988 A234G A235S V236C S237V Q239S ...     988/1056
(93 %)
27 diff
(97.5 %id)
BU557916 adenocarcinoma, cell line, breast .f 77 to 994 12 to 928 Y212I I213H V214R Y215V M216H ...     915/929
(98 %)
17 diff
(98.2 %id)
CR982406 T-Lymphocytes .f 87 to 915 1 to 830 S7X E11X E22X E29X E31X ...     830/830
(100 %)
4 diff
(99.6 %id)
BG696729 skin .f 209 to 996 1 to 786       786/786
(100 %)
5 diff
(99.4 %id)
BF205609 muscle, rhabdomyosarcoma .f 231 to 1051 1 to 814       816/991
(82 %)
39 diff
(96.1 %id)
BF307161 muscle, rhabdomyosarcoma .f 231 to 1040 1 to 799       799/817
(97 %)
32 diff
(96.1 %id)
BQ276387 carcinoma, cell line, Prostate .f 287 to 1280 1 to 1009       1009/1055
(95 %)
37 diff
(96.5 %id)
BE792928 lung, small cell carcinoma .f 291 to 1058 1 to 759       759/955
(79 %)
17 diff
(98.3 %id)
BE279561 choriocarcinoma, placenta .f 319 to 1030 1 to 706       704/715
(98 %)
10 diff
(98.7 %id)
BG750750 eye, normal pigmented retinal epithelium .f 333 to 977 1 to 645       645/645
(100 %)
3 diff
(99.6 %id)
BM560091 amelanotic melanoma, cell line, skin .f 366 to 1339 12 to 993       982/1100
(89 %)
51 diff
(95.4 %id)
BM912949 amelanotic melanoma, cell line, skin .f 367 to 1143 1 to 781       781/1078
(72 %)
16 diff
(98.6 %id)
BQ638662 eye, retina .f 369 to 962 10 to 607       594/607
(97 %)
10 diff
(98.4 %id)
TI_1948242077   .f 372 to 890 1109 to 592     Submitted on the opposite strand 518/1306
(39 %)
65 diff
(95.1 %id)
BQ055795 lymph, lymphoma, cell line .f 436 to 1359 1 to 935       935/1052
(88 %)
26 diff
(97.6 %id)
BQ061425 lymph, lymphoma, cell line .f 436 to 1289 1 to 868       868/1098
(79 %)
28 diff
(97.5 %id)
BF530965 anaplastic oligodendroglioma with 1p/19qloss, brain .f 450 to 1244 1 to 790       790/1080
(73 %)
30 diff
(97.3 %id)
BG423653 Kidney, renal cell adenocarcinoma .f 455 to 1300 1 to 845       845/979
(86 %)
31 diff
(96.9 %id)
AA203717 liver and spleen .f 511 to 1097 1 to 584       584/907
(64 %)
21 diff
(97.7 %id)
BQ050334 leiomyosarcoma, uterus .f 539 to 1077 1 to 541       541/1269
(42 %)
15 diff
(98.9 %id)
BM752925 Ascites, stomach .f 543 to 1027 1 to 486       486/486
(100 %)
3 diff
(99.4 %id)
CN345832 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 562 to 1186 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
AA488583   .f 569 to 1013 1 to 444   fully sequenced,   444/444
(100 %)
2 diff
(99.6 %id)
BG108537 Bone, osteosarcoma, cell line .f 594 to 1401 1 to 805       805/885
(90 %)
24 diff
(97.3 %id)
BF954621 nervous_normal .f 618 to 929 1 to 321       329/330
(99 %)
10 diff
(97.0 %id)
BE614560 leiomyosarcoma, uterus .f 621 to 1410 797 to 7       791/835
(94 %)
10 diff
(98.9 %id)
BE877663 large cell carcinoma, undifferentiated, lung .f 641 to 1388 1 to 744       744/781
(95 %)
12 diff
(98.5 %id)
CR989215 T-Lymphocytes .f 641 to 1352 1 to 715       715/722
(99 %)
6 diff
(99.2 %id)
BX337568 Placenta Cot 25-normalized .f 652 to 1376 727 to 1   fully sequenced,   727/727
(100 %)
5 diff
(99.4 %id)
AL580871 T cells from T cell leukemia .f 654 to 1392 753 to 14   fully sequenced,   740/753
(98 %)
3 diff
(99.7 %id)
BQ053900 blood, natural killer cells, cell line .f 656 to 1437 1 to 782       782/1061
(73 %)
8 diff
(99.3 %id)
TI_149288250   .f 673 to 1432 812 to 59   AAA   754/1007
(74 %)
14 diff
(98.7 %id)
TI_154130921   .f 673 to 1434 857 to 96   AAA   762/968
(78 %)
8 diff
(99.2 %id)
CU445993 epidermis .f 674 to 1154 496 to 16     Submitted on the opposite strand 481/504
(95 %)
7 diff
(98.7 %id)
T54561 fetal spleen, Spleen .f 677 to 1049 1 to 401       409/421
(97 %)
43 diff
(89.8 %id)
BQ231103 epithelioid carcinoma, Pancreas .f 682 to 1430 804 to 52   AAA Submitted on the opposite strand 753/865
(87 %)
53 diff
(93.9 %id)
AF147350   .f 687 to 1067 1 to 381       381/381
(100 %)
1 diff
(99.8 %id)
CA417884 Bone, Human Chondrosarcoma Cell Line .f 690 to 1434 764 to 19   AAA   746/747
(99 %)
3 diff
(99.6 %id)
BF834909 head_neck .f 695 to 1031 354 to 19     Submitted on the opposite strand 336/354
(94 %)
1 diff
(99.8 %id)
BE253502 eye, retinoblastoma .f 699 to 1403 1 to 705       705/714
(98 %)
7 diff
(99.1 %id)
TI_154097717   .f 705 to 1430 822 to 103   AAA   718/775
(92 %)
11 diff
(98.6 %id)
T54522 fetal spleen, Spleen .f 718 to 1061 357 to 9       349/360
(96 %)
8 diff
(97.8 %id)
TI_182940278   .f 728 to 1430 839 to 148   AAA   694/887
(78 %)
51 diff
(94.3 %id)
BQ354432 head_neck .f 741 to 1031 294 to 7       288/294
(97 %)
2 diff
(99.4 %id)
AL567801 brain, fetal brain .f 745 to 1403 658 to 1   fully sequenced,   658/658
(100 %)
2 diff
(99.7 %id)
BX402231.
matches multiple genes
placenta, Placenta Cot 25-normalized .f 745 to 1378 642 to 7   fully sequenced, also hits gene EFNA1 636/642
(99 %)
5 diff
(99.3 %id)
AL580047 T cells from T cell leukemia .f 745 to 1401 660 to 1   fully sequenced,   660/660
(100 %)
16 diff
(97.6 %id)
BX463336 adult brain, brain .f 745 to 1405 661 to 1   fully sequenced,   661/661
(100 %)
11 diff
(98.4 %id)
AA488443   .f 745 to 1015 269 to 1   fully sequenced,   269/269
(100 %)
2 diff
(99.3 %id)
TI_151767396   .f 748 to 1219 103 to 592       500/1103
(45 %)
70 diff
(93.7 %id)
BE613361 adenocarcinoma, ovary .f 755 to 1382 661 to 34       628/661
(95 %)
2 diff
(99.7 %id)
BE612629 adenocarcinoma, ovary .f 756 to 1431 1 to 676       676/968
(69 %)
10 diff
(99.0 %id)
TI_227713030   .f 775 to 1430 800 to 148   AAA   655/911
(71 %)
78 diff
(91.5 %id)
CA423432 cell lines, Chondrosarcoma .f 776 to 1436 679 to 19   AAA   661/661
(100 %)
3 diff
(99.6 %id)
BU681324 lung .f 778 to 1432 671 to 17   AAA   655/655
(100 %)
2 diff
(99.7 %id)
CA440822 lung, Metastatic Chondrosarcoma .f 787 to 1430 663 to 19   AAA   643/645
(99 %)
2 diff
(99.7 %id)
BM312965 Pancreas, Purified pancreatic islet .f 823 to 1437 618 to 6       613/618
(99 %)
1 diff
(99.9 %id)
CN429599 embryonic stem cells, DMSO-treated H9 cellline .f 868 to 1185 1 to 318       318/318
(100 %)
1 diff
(99.7 %id)
BM562284 leukocyte .g 1 to 909 20 to 944 L180R H205P T206P E209V A210R ... tiling clone,   925/1088
(85 %)
37 diff
(96.6 %id)
BM926630 pooled lung and spleen .h 1 to 843 20 to 865 H152T T153L E156* tiling clone,   932/1127
(82 %)
25 diff
(97.8 %id)
CR992104 T-Lymphocytes .i 1 to 913 1 to 914 A106C V107C H108S S109Q Q110P ... tiling clone,   914/914
(100 %)
4 diff
(99.6 %id)
DA179857 amygdala .j 1 to 442 2 to 450 exact tiling clone, capped   449/451
(99 %)
8 diff
(98.3 %id)
AW972230   Gene BRMS1, variant not shown         Submitted on the opposite strand    
BE932806 head_neck Gene BRMS1, variant not shown         Suspected internal deletion, this clone was ignored    
AA523547 colon Gene BRMS1, variant not shown         This clone was ignored    
AA579672 colon, colon tumor RER+ Gene BRMS1, variant not shown       AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS, this clone was ignored    
AI423656 brain, glioblastoma (pooled) Gene BRMS1, variant not shown         This clone was ignored    
AI804766 Prostate Gene BRMS1, variant not shown       AAA Suspected internal deletion, internal priming: the 3' end of the oligo dt primed clone lies in the CDS, this clone was ignored    
AI797564 pooled Gene BRMS1, variant not shown         Suspected internal deletion, this clone was ignored    
AW511392 pooled germ cell tumors Gene BRMS1, variant not shown         Suspected internal deletion, this clone was ignored    
BF435904 pooled Gene BRMS1, variant not shown         Suspected internal deletion, this clone was ignored    
BF939397 fibrotheoma, ovary Gene BRMS1, variant not shown       AAA This clone was ignored    
BG325665 Kidney, renal cell adenocarcinoma Gene BRMS1, variant not shown         Suspected internal deletion, this clone was ignored    
BU158550 large cell carcinoma, lung Gene BRMS1, variant not shown         Suspected internal deletion, this clone was ignored    
BU146806 brain, neuroblastoma, cell line Gene BRMS1, variant not shown         This clone was ignored    
CF130997 Chondrosarcoma Lung Metastasis cell lines, lung Gene BRMS1, variant not shown         Suspected internal deletion, this clone was ignored    
CR981740 T-Lymphocytes Gene BRMS1, variant not shown         Suspected internal deletion, this clone was ignored    
TI_154193754   Gene BRMS1, variant not shown         Suspected internal deletion, this clone was ignored    
DB252368 uterus Gene BRMS1, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI